Welcome

The Department of Cell Biology is committed to research excellence in modern cell biology, including the areas of protein targeting, membrane trafficking, signal transduction, cell-cell interaction & development, cell growth & division, viral infection and rare diseases. Our faculty is dedicated to quality in teaching at the undergraduate, graduate and postgraduate levels to develop a new generation of exceptional investigators. The development of cell biology as a discipline stems from the works of Claude, Palade and deDuve in which these pioneers made the first successful attempts to link cellular structure with biochemical functions. Today, cell biology combines aspects from many disciplines such as molecular biology, biochemistry and morphology, molding them into a unique approach towards the examination of cell function. Currently the Department of Cell Biology is home to a unique and diverse group of 10 Principal Investigators. Our faculty members are nationally and internationally recognized in experimental cell biology.

Our mission is to develop and provide the highest quality educational programs in cell biology. The active research environment created by members of the Department has the training of students as a top priority. Our goal within this environment is to train and develop highly qualified students who will go on to productive health science related careers. The Department of Cell Biology is committed to a tradition of excellence and innovation in teaching as part of the Faculty of Medicine and Dentistry at the University of Alberta.

The department, with investments from the Faculty of Medicine and Dentistry, Faculty of Science and the Learning Design Studio (formerly the Office of Academic Technologies) has secured a 3-year institutional site license for PyMol - a molecular modeling software.  Acquire your license here and get started with 3D molecular visualization.

  

Researcher takes another step toward discovering how a brain molecule could halt MS

 

A University of Alberta researcher is one step closer to demonstrating the potential of a brain molecule called fractalkine to halt and even reverse the effects of multiple sclerosis and other neurodegenerative diseases.  Read full article here.